Related references
Note: Only part of the references are listed.Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update
Nigel S. Key et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial
Robert D. McBane et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Risk of intracranial bleeding in patients with primary brain cancer receiving therapeutic anticoagulation for venous thromboembolism: A meta-analysis
Angelo Porfidia et al.
BRAIN AND BEHAVIOR (2020)
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer
Giancarlo Agnelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): A systematic review and meta-analysis
Ang Li et al.
THROMBOSIS RESEARCH (2019)
Intracranial hemorrhage with direct oral anticoagulants in patients with brain tumors
B. J. Carney et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Venous thromboembolism and intracranial hemorrhage after craniotomy for primary malignant brain tumors: a National Surgical Quality Improvement Program analysis
Joeky T. Senders et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)
Annie M. Young et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
Gary E. Raskob et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Risk of intracranial hemorrhage associated with therapeutic anticoagulation for venous thromboembolism in cancer patients: a systematic review and meta-analysis
Cristhiam M. Rojas-Hernandez et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2017)
Predicting the higher rate of intracranial hemorrhage in glioma patients receiving therapeutic enoxaparin
Charlene Mantia et al.
BLOOD (2017)
Antithrombotic Therapy for VTE Disease CHEST Guideline and Expert Panel Report
Clive Kearon et al.
CHEST (2016)
A meta-analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation
J. I. Zwicker et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Intracranial hemorrhage in cancer patients treated with anticoagulation
Matthew J. Weinstock et al.
THROMBOSIS RESEARCH (2016)
Intracranial hemorrhage in patients with brain metastases treated with therapeutic enoxaparin: a matched cohort study
Jessica Donato et al.
BLOOD (2015)
Venous thromboembolism in malignant gliomas
E. O. Jenkins et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma
J. R. Perry et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Management of venous thromboembolism in patients with primary and metastatic brain tumors
DE Gerber et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
S Schulman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer
AYY Lee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Share Paper
